|
Volumn 105, Issue 10, 2010, Pages 1505-
|
Renin-Angiotensin System Blockade for Diabetic Nephropathy Prevention
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANDESARTAN;
ENALAPRIL;
LOSARTAN;
PLACEBO;
CLINICAL TRIAL;
DIABETIC NEPHROPATHY;
DRUG DOSE INCREASE;
DRUG RESPONSE;
GLOMERULUS FILTRATION RATE;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
LETTER;
MICROALBUMINURIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BENZIMIDAZOLES;
DIABETES MELLITUS, TYPE 1;
DIABETIC NEPHROPATHIES;
ENALAPRIL;
FEMALE;
HUMANS;
LOSARTAN;
MALE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RENIN-ANGIOTENSIN SYSTEM;
RISK ASSESSMENT;
TETRAZOLES;
TREATMENT OUTCOME;
|
EID: 77951670581
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjcard.2010.02.004 Document Type: Letter |
Times cited : (1)
|
References (5)
|